Articles by James Calloway
Glencore Holds Steady on $2 Billion Payout Amid Mixed 2025 Results
Glencore's stock showed minimal movement following its 2025 financial report, which included a $2 billion capital return plan and earnings that exceeded analyst expectations despite a decline.
HSBC Shares Gain Amid U.S. Team Cuts Ahead of Key Earnings
HSBC Holdings saw its London-listed shares advance approximately 0.3% early Friday, while its U.S. ADR declined. The move follows a report of staff reductions in the bank's U.S. bond-deal team, setting the stage for its upcoming annual earnings release.
Rio Tinto Shares Gain Despite Earnings Shortfall, Outlines Strategic Shifts
Rio Tinto's London-listed shares advanced 0.5% despite posting flat 2025 underlying earnings that fell short of forecasts. The company boosted its lithium investment and reaffirmed its dividend policy.
BAE Systems Retreats from Record High as Investors Digest Strong Outlook
BAE Systems shares pulled back from a 52-week high in early London trading, even as the defence contractor posted robust annual results and issued strong forward guidance. The company's order backlog reached a record level.
Rolls-Royce Executes Share Repurchase Ahead of Key Earnings Report
Rolls-Royce Holdings acquired 450,000 shares on February 19 as part of its £200 million repurchase initiative, paying between 1,307p and 1,322p per share. The company's stock remains near yearly highs as markets anticipate annual results scheduled for February 26.
Lynas Gains Ahead of Key Earnings as Rare Earth Prices Rally
Lynas Rare Earths shares advanced Friday, supported by rising rare earth prices. The market now focuses on the company's half-year results due February 26.
PLS Shares Slide on Profit, Dividend Decision, and Plant Restart Plan
PLS Group shares declined 4.6% to A$4.18 after the company reported a first-half net profit of A$33 million but opted against an interim dividend. The board also approved a July 2026 restart for the Ngungaju processing plant.
Pro Medicus Shares Dip Ahead of Dividend Date Amid Contract Timing Scrutiny
Pro Medicus shares declined 2.1% to A$126.51, with attention turning to its upcoming ex-dividend date and analyst focus on contract timing issues affecting recent earnings.
Telix Soars on Strong Revenue Growth and Upbeat 2026 Forecast
Telix Pharmaceuticals shares jumped 14.2% following the release of its full-year results, which showed a 56% revenue increase to US$803.8 million for 2025 and a forecast for 2026 revenue between US$950 million and US$970 million.
Mineral Resources Shares Slump Despite Record Earnings, Focus Shifts to Debt
Mineral Resources Ltd shares dropped 5.3% despite reporting record first-half earnings, as the market focused on the company's decision to skip its interim dividend and its ongoing debt reduction efforts.
Whitehaven Coal Slides on H1 Loss, Launches Modest Buyback
Whitehaven Coal shares declined 2.7% to A$7.81 following the release of first-half results showing an underlying net loss and the commencement of a limited buyback.
Woolworths Shares Slide Ahead of Key Earnings Amid Regulatory Pressure
Woolworths shares declined 2.3% on Friday, closing at A$31.23, as regulatory scrutiny intensifies ahead of the company's half-year financial report scheduled for February 25.